Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eliminate Trial: Omission of Radiotherapy in pN0/N1 Oral Cavity Carcinomas
NCT07528495Phase 3Recruiting
- Sponsor
- AIIMS New Delhi
- Start
- Apr 2024
- Primary completion
- Dec 2027
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in oral cavity squamous cell carcinoma (OCSCC) (2 arms), sponsored by AIIMS New Delhi. Primary endpoint: Regional control at 2 years. Started Apr 2024; status: recruiting.
02
Conditions
oral cavity squamous cell carcinoma (OCSCC)
Beyond the preview
Go deeper on NCT07528495.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07528495.